Sandbox:skorjian2
‘’’Adjuvant therapy’’’
- Interferon alfa-2a (Roferon-A)
- Interferon alfa-2b (Intron-A)
- Peginterferon alfa-2b (Sylatron)
‘’’Metastatic or unresectable disease’’’
- ‘’’’’Single Agent Chemotherapy’’’’’
- Dabrafenib (Tafinlar)
- Dacarbazine (DTIC)
- Docetaxel (Taxotere)
- High-dose (HD) IL-2
- IL-2 maintenance biotherapy
- Imatinib (Gleevec)
- Ipilimumab (Yervoy)
- Nivolumab (Opdivo)
- Paclitaxel (Taxol)
- Pembrolizumab (Keytruda)
- Temozolomide (Temodar)
- Trametinib (Mekinist)
- Vemurafenib (Zelboraf)
- ‘’’’’Combination Chemotherapy’’’’’
- Paclitaxel nanoparticle albumin-bound + Bevacizumab + Carboplatin (ABC)
- Carboplatin + Paclitaxel (CP)
- Carboplatin + Paclitaxel + nanoparticle albumin-bound
- Carboplatin + Paclitaxe +, Sorafenib
- Cisplatin + Dacarbazine ± Carmustine
- Cisplatin + Dacarbazine + IL-2 + IFN alfa-2b ± Carmustine
- Cisplatin + Paclitaxel + Dacarbazine
- Cisplatin + Vinblastine + Dacarbazine (CVD)
- CVD + IL-2 + IFN alfa-2b (sequential biochemotherapy)
- Temozolomide + Bevacizumab (TB)
- Dabrafenib + Trametinib
- Ipilimumab + Dacarbazine
- Ipilimumab + Nivolumab